To include your compound in the COVID-19 Resource Center, submit it here.

Phaging into arrays

Biosite Diagnostics Inc. believes it can make an interesting and sustainable business from in vitro diagnostics, using its Omniclonal phage display technology as leverage to gain access to new, proprietary disease targets under investigation by others. Last week's

Read the full 385 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE